文献速递头颈外科

头颈部鳞状细胞癌患者中炎症生物标志物与他汀类药物使用之间的关联

The association between inflammatory biomarkers and statin use among patients with head and neck squamous cell carcinoma.
PubMed 文献 · Head Neck · 2022-03-25

研究收集2008-2014年头颈部鳞状细胞癌(HNSCC)病例的医疗记录中的他汀使用情况,计数肿瘤组织中的肿瘤浸润淋巴细胞(TILs)并构建总加权评分(TILws),检测血液细胞因子。在HPV阳性患者中观察到使用他汀与TILs呈正相关(TILws比值比2.80,95%CI 1.03-7.61),HPV阴性患者中无关联;他汀与细胞因子无关联。作者认为他汀可能影响HPV阳性患者的TILs,这可能是其改善HPV阳性HNSCC患者预后的机制。

要点

  • HPV阳性HNSCC患者中使用他汀与TILws呈正相关(OR=2.80,95%CI 1.03-7.61)。
  • HPV阴性HNSCC患者中使用他汀与TILs无关联。
  • 他汀使用与血液细胞因子无关联。

核心结论

  • 他汀可能影响HPV阳性HNSCC患者的肿瘤浸润淋巴细胞,这可能是其改善该人群预后的机制。

研究设计与样本

  • 研究收集2008-2014年间头颈部鳞状细胞癌(HNSCC)病例的医疗记录中的他汀使用情况。

主要发现

  • 在HPV阳性患者中观察到使用他汀与TILs呈正相关(TILws比值比2.80,95%CI 1.03-7.61),而HPV阴性患者中无关联。
  • 观察到使用他汀与细胞因子无关联。

关键数值与推荐

  • 在HPV阳性患者中使用他汀与TILws的比值比为2.80(95%CI 1.03-7.61)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tumor-infiltrating lymphocytes (TILs) and cytokines are associated with prognosis among patients with head and neck squamous cell carcinoma (HNSCC). Statins (cholesterol-lowering drugs) may improve HNSCC prognosis, particularly in human papillomavirus (HPV)-positive cases, but the mechanism remains unclear. METHODS: Statin use was collected from medical records for HNSCC cases (2008-2014). TILs were counted in tumor tissue, and a total weighted score (TILws) was created. Cytokines were measured in blood. The associations between statins and biomarkers were estimated using logistic (biomarker categories: <median, ≥median) and linear regression models (log-transformed continuous biomarkers) adjusted for age, smoking, and comorbidities. RESULTS: We observed a positive association between statins and TILs among HPV-positive patients (TILws odds ratio [OR] = 2.80; 95% CI = 1.03-7.61), but no association among HPV-negative patients. We observed no association between statins and cytokines. CONCLUSIONS: Statins may influence TILs in HPV-positive patients. This may be the mechanism through which they improve prognosis in HPV-positive HNSCC patients.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Getz KR, Bellile E, Zarins KR, et al. The association between inflammatory biomarkers and statin use among patients with head and neck squamous cell carcinoma. Head Neck. 2022. PMID: 35338544. doi:10.1002/hed.27040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。